Vera Therapeutics, Inc.

NASDAQ:VERA

Biotechnology

Healthcare
$25.58 +0.27%

+$0.09 today

Market cap
$1.85B
Beta
0.95
P/E (TTM)
-6.8
EPS (TTM)
-$5.16
52W Low $19.07High $56.05

Volume 0.95M

Average 1.18M

VERA Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

No reported Operating Margin figures are available to summarize.

Operating Margin history

Percent of revenue · from the income statement

No Operating Margin data reported for this period type.

Operating Margin vs competitors

How VERA compares with its peers on the latest reported figures

VERA Competitors Peer median
Operating Margin for VERA and competitors
Company Period LTM level YoY 3-year change
ANABAnaptysBio, Inc.LTM Mar 202617.6% +107.2 pp+1139.8 pp
ARQTArcutis Biotherapeutics, Inc.LTM Jun 20267.4% +40.0 pp+8179.8 pp
PHARPharming Group N.V.LTM Mar 20266.3% +6.1 pp-3.3 pp
ACRSAclaris Therapeutics, Inc.LTM Mar 2026-961.9% -168.3 pp-673.9 pp
ALMSAlumis Inc. Common StockLTM Jun 2026-6204.4% -4015.0 pp—
DNTHDianthus Therapeutics, Inc.LTM Jun 2026-11441.4% -8764.8 pp-8276.4 pp
VERAVera Therapeutics, Inc.FY2025— ——
BHVNBiohaven Ltd.FY2025— ——
MLTXMoonLake ImmunotherapeuticsFY2025— ——
KYTXKyverna Therapeutics, Inc.FY2025— ——
Peer median (excluding VERA) -477.8%-81.1 pp-3.3 pp

Competitors are the stored peer set for VERA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue0(846K)000
Gross Profit0846K000
Gross Margin—————
Research & Development22.48M69.84M78.23M126.17M215.26M
Selling, General & Admin11.92M21.91M23.79M41M100.22M
Operating Expenses34.4M91.75M102.01M167.17M315.47M
Depreciation & Amortization176K(846K)21K105K468K
EBITDA(32.41M)(88.91M)(92.18M)(144.42M)(291.62M)
EBITDA Margin—————
Operating Income(34.4M)(90.9M)(102.01M)(167.17M)(315.47M)
Operating Margin—————
Interest Income15K1.75M7.98M20.71M24.48M
Interest Expense20K992K3.79M7.63M7.53M
Other Income / Expenses1.79M1.85M6.02M15.02M15.86M
Income Before Tax(32.61M)(89.06M)(95.99M)(152.15M)(299.61M)
Pre-Tax Margin—————
Income Tax Expense1K1K1K1K1K
Net Income(32.61M)(89.06M)(95.99M)(152.15M)(299.62M)
Net Margin—————
EPS (Basic)(2.43)(3.35)(2.25)(2.75)(4.66)
EPS (Diluted)(2.43)(3.35)(2.25)(2.75)(4.66)
Weighted Avg Shares13.44M26.57M42.71M55.33M64.23M
Weighted Avg Shares (Diluted)13.44M26.57M42.71M55.33M64.23M

Vera Therapeutics, Inc.

NASDAQ:VERA

Intrinsic Alpha fair value

Locked

Current Price

$25.58

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.